Amphastar Pharmaceuticals, Inc. (AMPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.25B |
| Enterprise Value | 1.74B |
| P/E Ratio | 12.41 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 1.3 |
| Price/Book Ratio | 1.23 |
| Enterprise/Revenue | 1.94 |
| Enterprise/EBITDA | 8.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 719.89M |
| Revenue/Share | 16.73 |
| Gross Profit | 356.06M |
| EBITDA | 212.31M |
| Net Income | 98.09M |
| Diluted EPS | 2.03 |
Balance Sheet
| Total Cash | 290.12M |
| Total Cash/Share | 6.65 |
| Total Debt | 688.32M |
| Total Debt/Equity | 0.9 |
| Current Ratio | 2.4 |
| Book Value Per Share | 17.6 |
Price History
| 52-Week Change | -29.18 |
| 52-Week High | 31.26 |
| 52-Week Low | 16.65 |
| Moving Average 50 Days | 20.01 |
| Moving Average 200 Days | 22.68 |
Statistics
| Average Volume | 521,808 |
| Shares Outstanding | 44.09M |
| % Held by Institutions | 63.11 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
